The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move reflecting institutional confidence in large-cap value and growth stocks, CIBC Asset Management has significantly bolstered its positions in several leading US entities. According to reports, the firm increased its stake in RTX Corporation by 46.8%, bringing the total value of its holding to $65.3 million, and raised its position in Philip Morris International by 39.5% despite the tobacco giant's lowered annual profit guidance. Furthermore, the asset manager added shares in Amgen and Texas Instruments following their robust quarterly earnings reports.
Sign in to access this content
Sign InThese adjustments occur amid shifting momentum in the defense and technology sectors, where market data shows RTX outperforming peers like Lockheed Martin due to raised guidance and strong order backlogs. For Philip Morris, the increased institutional backing comes despite a significant writedown in Canada, suggesting a strategy of accumulating shares during temporary headwinds. Recent earnings research indicates that new drug approvals have been a primary catalyst for Amgen, justifying the increased exposure by major asset managers.
Looking ahead, investors are monitoring price stability as major economic indicators are released, including the May 28, 2026, GDP data which showed 1.6% growth, missing the 2% forecast. Market participants should watch for upcoming Fed official speeches as catalysts for broader market sentiment. Sustained institutional buying at these levels often provides a floor for large-cap stocks, though macroeconomic data regarding inflation and interest rates remains the primary driver for near-term volatility.